SARS-CoV-2 - MeSH

Search results

Items: 1 to 20 of 43

<< First< Prev

Page of 3

Select item 20521801.

A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis.

Year introduced: 2021(2020)

Select item 20993062.

SARS-CoV-2 variants [Supplementary Concept]

Sequence variants of SARS-COV-2 virus when compared to the reference sequence (NC_045512.2). Many are under investigation for various mutations and their potential impact on COVID-19 (e.g, transmissibility, diagnosis, vaccine effectiveness or clinical presentation or severity). For instance variant B.1.1.7 is characterized by a set of mutations including N501Y on the spike protein which binds human ACE2 PROTEIN. There are more than 900 registered variants as of February 2021.

Select item 20505203.

ORF1ab polyprotein, SARS-CoV-2 [Supplementary Concept]

Gene ID: 43740578

Select item 20853264.

3C-like proteinase, SARS-CoV-2 [Supplementary Concept]

Select item 20522195.

COVID-19 Serological Testing

Diagnosis of COVID-19 by assaying bodily fluids or tissues for the presence antibodies specific to SARS-COV-2 or its antigens.

Year introduced: 2021

Select item 21020816.

Baiya SARS-CoV-2 VAX COVID-19 vaccine [Supplementary Concept]

plant (Nicotiana benthamiana) produced SARS-CoV-2 receptor binding domain protein subunit vaccine

Select item 20890817.

nucleocapsid phosphoprotein, SARS-CoV-2 [Supplementary Concept]

RefSeq NC_045512

Select item 20521918.

COVID-19 Vaccines

Vaccines or candidate vaccines containing SARS-CoV-2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent COVID-19.

Year introduced: 2021

Select item 21005459.

SARS-CoV-2 recombinant spike protein with delta inulin and CpG-ODN adjuvant vaccine [Supplementary Concept]

Select item 205229810.

papain-like protease, SARS-CoV-2 [Supplementary Concept]

Select item 205031711.

spike protein, SARS-CoV-2 [Supplementary Concept]

Select item 205219612.

COVID-19 Testing

Diagnosis of COVID-19 by assaying bodily fluids or tissues for the presence of COVID-19 antibodies, SARS-COV-2 antigens or the VIRAL RNA of SARS-COV-2.

Year introduced: 2021

Select item 205217913.

COVID-19

A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. A coronavirus, SARS-CoV-2 VIRUS, in the genus BETACORONAVIRUS is the causative agent.

Year introduced: 2021(2020)

Select item 210323314.

COVID-19 Serotherapy

Transfer of blood plasma derived from patients who have recovered from COVID-19 to non-immune hosts.

Year introduced: 2023 (2020)

Select item 210213115.

NS13 protein, SARS-CoV-2 [Supplementary Concept]

GenBank QHD43415

Select item 208532916.

NSP12 protein, SARS-CoV-2 [Supplementary Concept]

Select item 205094117.

NS8 protein, SARS-CoV-2 [Supplementary Concept]